Home | About Us | Partner | Forms | Help | Contact
  Home » Medicine & Biology » EMI81011515(C)
By Types
  Statistical Yearbook
     Province & City

     Province & City

     Province & City

     Province & City

     Province & City

  Yellow Pages
     Province & City


  Text Book
     Applied Linguistics on TCSL
     Books for Teachers (TCSL)
     Children and Teenagers
     HSK Tests

  View All Books
By Industries


  Building & Construction


  Culture & Literature




  Energy & Utilities


  Financial Services

  Food & Beverage



  IT & Telecom

  Laws & Policies

  Learning Chinese



  Medicine & Biology

  Media & Entertainment

  Science & Technology

  Society & Life

  Tourism & Hotel

  View All Books
By Publishers more
Pharmacopoeia of the People’s Republic of China 2015 (Set of 4, Chinese edition)
Description Table of Content
Publisher : China Medical Science and Technology Press
Published Date : 6/2015
Language : Chinese
ISBN/ISSN : 9787506773379 / 9787506773430 / 9787506773362 / 9787506775397
Weight : 10.00kg
Availability : Usually ship within one week
Book Type : Reference
Remarks : A Set of 4 Volumes
Estimated Shipping Time

In February 4, 2015, the people's Republic of China Pharmacopoeia 2015 version of the tenth Pharmacopoeia Committee of the Executive Committee of the plenary meeting considered and adopted. June 5th, the State Food and Drug Administration officially promulgated the people's Republic of China Pharmacopoeia 2015 edition, December 1st implementation. The promulgation of the new pharmacopoeia marks the level of China's drug use, pharmaceutical levels and the comprehensive improvement of the level of supervision, will promote the overall improvement of drug quality, for the protection of public safety and effective use of drugs.

"Pharmacopoeia of the people's Republic of China" is a part of the national drug standards, the core of the national drug standards system. In accordance with the Party Central Committee proposed the "four most stringent" requirements, the new version of the Pharmacopoeia system has always adhere to the "scientific, advanced, practical, standardized" principle, based on experimental data, research results, expert evaluation, reflecting the scientific and rigorous Pharmacopoeia, to continue to improve the quality of high quality. At the same time, through strict supervision, to ensure the implementation of standards and the implementation of the "people's Republic of China," the authority of the.

New pharmacopoeia to further expand the collection and revision of drug varieties, a total of 5608 kinds of species. Volume One containes 2598 species, including 440 new species. Volume Two contains 2603 kinds of new varieties, including 492 kinds of new varieties. Volume Three contains 137 species of the collection, including 13 new varieties, the revision of the 105 species. On the first edition of the Pharmacopoeia of the Pharmacopoeia of the general rules, and with the medicinal materials as a separate volume as the new version of the Pharmacopoeia four. Volume Four contains general rules of the total number of 317, including general rule 38, detection method 240, guiding principle 30, standard substance and control the general rule 9; medicinal materials collected 270 kinds, including 137 kinds of new, revised 97.

The new edition of the Pharmacopoeia marks a new stage in China's pharmaceutical standards. Mainly embodied in five aspects: one is the new edition of Chinese Pharmacopoeia of explanatory notes, general, general of the comprehensive revision, enhancing the overall quality control requirements. Two is to further expand the application of advanced and mature detection technology, focusing on strengthening the safety and effectiveness of drug control requirements, the scientific nature of the Pharmacopoeia standards, advanced, normative further strengthen. Three is through the scientific selection of varieties, improve detection capabilities, strict regulations, improve the technical guidance and other measures, so that the leading role of Pharmacopoeia standards and technology oriented role significantly enhanced. Four is the standard of medicinal materials used to receive a substantial increase in the variety of varieties, quality control level and safety of accessories. Five is to improve the standard system of the Pharmacopoeia of the construction, strengthen the quality management of the concept, strengthen the "people's Republic of China Pharmacopoeia" in the national drug standards in the core position.

To improve the overall level of China's pharmaceutical quality, the new version of the Pharmacopoeia will focus on the role of the four aspects. Is play to safeguard public health, protect the safe and effective use of the "protective wall" effect; second is to play a leading industrial structure adjustment and upgrading the quality of the "Navigator" role; play to enhance the competitiveness of enterprises "booster" effect; four is to play the Chinese pharmaceutical achieve quality hard commitment, leading to the "Rainbow Bridge" effect of the internationalization of the road. The General Administration of China will promote the improvement of pharmaceutical quality and accelerate the development of enterprises and products, and promote the healthy development of China's pharmaceutical industry.
Pharmacopoeia of the People’s Republic of China 2015 (Set of 4, Chinese edition)

  Add to Wish List   
Relative Books
Shopping Cart more
0 items
Best Sellers
01.Pharmacopoeia of the People’s Republic of China 2010 (Set of 3, English edition)
02.Pharmacopoeia of the People’s Republic of China 2015 (Set of 4, Chinese edition)
03.Pharmacopoeia of the People’s Republic of China 2010 (Set of 3, Chinese edition)
04.Pharmacopoeia of the People’s Republic of China 2015 (English Edition) (Set of 4 Volumes)
05.Library of Chinese Classics: YELLOW EMPEROR’S CANON OF MEDICINE PLAIN CONVERSATION (Chinese-English)
06.Pharmacopoeia of the People’s Republic of China 2005 (Set of 3, English edition)
07.Annual Report of Cancer Registration in China 2011
08.China Medical Market Development Blue Book 2011
09.Acupuncture for Musculoskeletal Injury (2nd Edition)
10.Annual Report of Cancer Registration in China 2009
Specials more
China Industry Economy Yearbook 2008
China Industry Economy Yearbook 2008
 US$121.67  US$115.58 
Latest books more
HS Code Commodity Classification English / Chinese References
Help more
Top Buyers
02.United States
06.Russian Federation
09.Korea, Republic of
  Friday 19 July, 2019   | Home| About Us | Partner | Forms | Help| Terms and Conditions| Privacy Statement| Site Map | Contact |  Top - | Catalog RSS Feed
Copyright © 2004 - 2014 SUNRILL INFORMATION LIMITED 
Alias domains: 

Your China statistical database: